Pharma Pathway

JANUARY 7, 2023

Hetero Limited-Campus Interview for B.Sc / M.Sc -Chemistry/ B.Com/ B.Pharm/ ITI Fitter/ Diploma Mechanical On 9th Jan’ 2023. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Date of Interview: 9th Jan’ 2023. Job Description.

Biosimilars 88

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 88

Pharma Pathway

MARCH 3, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & Experienced in QC -Instrumentation On 4th Mar’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Dear, Greetings from Hetero…!!

Biosimilars 80

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 80

Pharma Pathway

FEBRUARY 20, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in Production/ QA/ QC/ Maintenance On 21st Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 78

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 78

Pharma Pathway

FEBRUARY 3, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & Experienced in Production/Packing/ QA/ Stores On 4th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 82

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 82

Pharma Pathway

FEBRUARY 4, 2023

Walk-In Interviews for fresher -Apprentice Trainee On 8th Feb’ 2023 Job Description Dr. Reddy’s Laboratories Ltd. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Walk-In Interviews for fresher -Apprentice Trainee On 8th Feb’ 2023

Biosimilars 86

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 86

Pharma Pathway

FEBRUARY 2, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in Quality Control/ Quality Assurance/ Production On 5th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Chemist Qualification: B.Sc

Biosimilars 80

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 80

Pharma Pathway

FEBRUARY 16, 2023

in Regulatory Affairs On 17th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Biosimilars 72

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 72

Pharma Pathway

JANUARY 30, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in QA/ QC/ Production On 3rd Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 72

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 72

Pharma Pathway

JANUARY 24, 2023

Hetero Labs Limited-Walk-In Interviews for Quality Control/ Quality Assurance/ Engineering/ Safety -EHS On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 74

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 74

Pharma Pathway

JANUARY 5, 2023

Walk-In Drive for Multiple Positions On 8th Jan’ 2023. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Job Description.

Biosimilars 86

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 86

Pharma Pathway

JANUARY 26, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in QC/ QA/ R&D/ Production/ HR/ Maintenance On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 78

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 78

Express Pharma

APRIL 18, 2024

a specialty pharmaceutical company in Brazil, for the commercialisation of its vertically integrated drug product, Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 diabetes. The post Biocon signs licensing and supply pact with Biomm S.A

Diabetes 102

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 102

Pharma Pathway

JANUARY 24, 2023

Hetero Labs Limited-Walk-In Interviews for AR&D/ FR&D/ Analytical DQA On 28th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Method Validation 79

Method Validation Biosimilars Pharmaceutical Companies Pharmaceutical Companies 79

Pharma Pathway

FEBRUARY 21, 2023

Hetero Labs Limited-Walk-In Interviews for Production On 26th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

FEBRUARY 17, 2023

Hetero Labs Limited-Walk-In Drive for Any Graduate in Production- API On 19th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

JANUARY 5, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & Experienced On 6th & 7th Jan’ 2023. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

APRIL 1, 2022

Congress and the White House to curtail prescription drug prices, many experts continue to point to biosimilars and their promising potential to usher in competition, increase access, and drive down costs for patients—and the U.S. And already in the first quarter of 2022, the FDA approved a third filgrastim biosimilar, Releuko.

Biosimilars 59

Biosimilars Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Pathway

JANUARY 4, 2023

On 8th Jan’ 2023. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Company Name: Dr. Reddy’s Laboratories.

Biosimilars 82

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 82

Pharma Pathway

FEBRUARY 4, 2023

Hetero Labs Limited-Campus Drive for B.Sc /B.Pharm/ M.Sc/ BCCA/ ITI Fitter/ Diploma/ B.Com/ Diploma Freshers On 6th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

FEBRUARY 27, 2024

Amgen drug development highlights – November 2023 In November 2023, Phase II trial results for immunotherapy tarlatamab demonstrated an ability to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer trial patients.

Biosimilars 99

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 99

Pharma Pathway

FEBRUARY 27, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & experienced in Production/ Packing/ QC/ QA/ Stores On 4th March 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Dear, Greetings from Hetero…!!

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

OCTOBER 6, 2023

Biocon has signed a partnership agreement with Juno Pharmaceuticals, a specialty pharmaceutical company in Canada, for the commercialisation of its vertically integrated, complex formulation, Liraglutide, a drug-device combination for the treatment and management of Type 2 diabetes and obesity.

Diabetes 102

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 102

Pharma Pathway

DECEMBER 7, 2022

Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics. Time: 10:00 AM Onwards. hetero.com.

Biosimilars 87

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 87

PharmaShots

MARCH 29, 2023

Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years. Currently, the drug is not accessible in generic form.

Biosimilars 49

Biosimilars Diabetes Chemotherapy Immunity 49

European Pharmaceutical Review

NOVEMBER 8, 2022

2) limiting the scope and number of patents asserted in litigation against proposed biosimilar entrants. 4) prohibiting ‘product hopping’ and interference with generic and biosimilar substitutions. 5) monitoring access to biosimilars. 3) policing anticompetitive settlements between competing drug manufacturers.

Biosimilars 52

Biosimilars Drug Pricing Pharmaceutical Manufacturing Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 8, 2023

Pfizer is likely to continue maintaining its position by breaking into the race for a respiratory syncytial virus (RSV) vaccine; it is currently awaiting FDA marketing approval for its RSV vaccine, which was awarded priority review with a PDUFA date decision in May 2023.

Vaccines 78

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 78

PharmaShots

JUNE 7, 2023

Our team at PharmaShots has summarized 16 key events of the biosimilar space of May 2023 1. based on change from baseline on a standardized DAS28-CRP which evaluates the severity of RA using clinical and laboratory data Additionally, the company initiates PK study for AVT05 in Jan 2023. 84% vs 64%) & 2yr. (60%

Biosimilars 40

Biosimilars Packaging Diabetes Pharmaceutical Companies 40

European Pharmaceutical Review

APRIL 13, 2023

Legislative hurdles aside, in the same way as any other pharmaceutical companies, psychedelics companies will need to obtain regulatory approvals in the countries where they will carry out clinical trials or market products. Sian Banks is a Solicitor within Pinsent Masons’ international intellectual property group.

Biosimilars 114

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 114

Big Molecule Watch

JUNE 6, 2023

On May 26, 2023, the European Commission granted the marketing authorization to Samsung Bioepis for EPYSQLI, a biosimilar referencing SOLIRIS (eculizumab) developed by Alexion for the treatment of the paroxysmal nocturnal hemoglobinuria (PNH) that had global sales of approximately $5 trillion last year.

Biosimilars 57

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 57

Pharmaceutical Technology

JANUARY 30, 2023

on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. Full details of the government’s 2023 VPAS payment calculation may be accessed on the UK Department of Health and Social Care (DHSC) page here. billion ($4.1

Biosimilars 97

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Vaccines 97

PharmaShots

FEBRUARY 27, 2023

Some of their thoughts are: Mr. Mekala Rao (Chairman – Technology Global PHT Expo & Summit – 2023 and President – Atachi Systems, USA) – “motivation to attend Global PHT is to understand the cultural gap in the production of innovative medicine, healthcare systems between eastern and western world.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

PharmaState Academy

MAY 16, 2023

Over the next 15 to 20 years, you can expect pharma business models of today to be metamorphosed by biopharmaceuticals and biosimilars. 7) An analysis of ten pharmaceutical companies by Boston Consulting Group revealed the average production cost per pack was ca. $5 5 for small molecules and ca. $60 60 for biologics.

Biosimilars 52

Biosimilars Dosage Pharmaceutical Companies Pharmaceutical Companies 52

FDA Law Blog: Biosimilars

AUGUST 22, 2023

At the time, we spoke with Laura Brett, Vice President and New York Office Leader at BBB National Programs who confirmed that NAD has always been able to review prescription pharmaceutical claims, even if it has been underutilized in doing so. Can we expect more enforcement from OPDP in 2023 in response to trade complaints?

Communication 40

Communication Pharmaceutical Companies Pharmaceutical Companies 40

FDA Law Blog: Biosimilars

DECEMBER 18, 2023

The letters, both issued on October 31, 2023 but published in early November, were to Otsuka and Evofem for misleading efficacy claims relating to overstating the efficacy of their respective products in direct-to-consumer (DTC) advertisements.

Labelling 59

Labelling Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

JANUARY 16, 2023

Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The entire pharma industry will be affected by the fallout.

Drug Pricing 64

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 64

Pharmaceutical Technology

JANUARY 16, 2023

Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The entire pharma industry will be affected by the fallout.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52